XOMA 358
Selinexor - STORM
BL-8040
Lasmiditan - SAMURAI
YOSPRALA (PA32540/PA8140) 
TG-1101
Odalasvir (ACH-3102), simeprevir and ALS-335
ALN-GO1
Remoxy
Remoxy
ARB-1467
A-101
ARX-04 (SAP303)
Roclatan - Mercury trials
Rhopressa
ALD403 
Binimetinib - COLUMBUS
VIBEX QuickShot
ECCO-50 cellular therapeutic
Locilex
DUR-928 
Bempedoic acid (ETC-1002-035)
Migalastat HCl monotherapy (012)
GEN-003
Epidiolex
Duvelisib - DUO
Auryxia
KTE-C19 (ZUMA-1)
MPC-300-IV
Ganaxolone
ANX-188 - Vepoloxamer
RSV vaccine - Resolve trial
Custirsen  in combination with Jevtana (cabazitaxel)- AFFINITY
Enclomiphene
Sparsentan (DUET) 
Tarloxotinib
Tarloxotinib
TNX-102 SL 
ASP0113 Vaccine
ORKAMBI
CRLX101 and paclitaxel
Glembatumumab vedotin
Egalet-001
Aerosurf
XTANDI
QR-010 
Vascepa REDUCE-IT outcomes trial
Blisibimod
Cogenzia
XaraColl 
Tovaxin (Tcelna)
Bremelanotide
Revefenacin
Ibalizumab 
Lonafarnib - LOWR HDV – 2
Lonafarnib - LOWR HDV – 4
Lonafarnib - LOWR HDV – 3
PCSKsi - ORION-1 
MDCO-216 - MILANO-PILOT
Telotristat etiprate
Fostamatinib 
LentiGlobin 
LentiGlobin - HGB-206
Apaziquone
HEPLISAV-B 
Solithera - oral
Lutathera
Solithera - intravenous
BL-8040
Pimavanserin
ACH-4471
Dalfampridine
A-101
Zalviso
ADS-5102 - EASE LID trial
CRS-207 and GVAX Pancreas and nivolumab - STELLAR trial 
Macimorelin Acetate - Macrilen
Zoptrex
Twirla
ALKS 5461
ALN-TTRsc02
Sollpura (liprotamase)
Vitaros
Pulmaquin -  ORBIT-3 and ORBIT-4
AGS-003 
Iclusig (ponatinib)
APD334
Vapendavir - SPIRITUS trial
Nelotanserin 
Clonidine gel
INOpulse delivery device
ONT-380 and T-DM1
CAT-1004 
CCX872
CCX168 
Solithromycin
CERC-501
CRLX101 in Combination with Chemotherapy and Radiation
CHS-1420
CLBS03
Twirla
Resunab
Resunab
Neutrolin - LOCK-IT 100
CMX157
Sapacitabine (SEAMLESS)
APL-130277 - CTH-300
Aldoxorubicin with doxorubicin
Aldoxorubicin
Aldoxorubicin
DTX101
DCR-MYC
AM-101 - TACTT3
Subcutaneous exendin
Recurrent endometrial cancer
Zilretta - FX006
ATB200
FDX103
NeuVax in combination with Herceptin
GS-4774 - 1401 trial
GI-6207
Enobosarm 
Enobosarm 
Epidiolex
Sativex
PEGPH20 
HTX-019
HS-410
HS-110
ACTIMMUNE
IMO-2125
Kadcyla KRISTINE trial
Ruxolitinib
Buprenorphine
IONIS-FXIRx
IONIS-STAT3-2.5Rx
Linaclotide Colonic Release
ITI-007-302
Trabodenoson
Selinexor - STOMP
Selinexor SOPRA
KIT-302
Tipifarnib
Resolaris
OXi4503 
CA4P Fosbretabulin
NFC-1
Enzalutamide
Progressive multiple sclerosis (progressive MS)
MCLA-128
MCLA-117
NBI-98854 (Valbenazine)
ND0612H (Trial 006)
Cipro DPI 
NKTR-214
RSV F Vaccine rollover trial 
Tumor Treating Fields (TTFields) - PANOVA
DEXTENZA
Apatorsen Borealis-2
SPK-CHM
SPK-RPE65
Fovista
hGH-CTP
OTIPRIO
Neratinib SUMMIT
Neratinib monotherapy with high dose loperamide prophylaxis
1404
PRX-110 
PRX-106
Vonapanitase (PRT-201) PATENCY-1 
Betrixaban (The APEX Study)
Cerdulatinib (PRT2070)
AMT-060
KRN23
UX007 (triheptanoin)
UX007 (triheptanoin)
RIZAPORT (RHB-103)
RHB-104 MAP US
RHB-104 CEASE-MS
Intravenous (IV) meloxicam 
Fostamatinib
Supinoxin
RX-3117
Proellex
Proellex
RT002
Samcyprone - RXI-SCP-1502
 RXI-109-1402
Samcyprone - RXI-SCP-1502
RXI-109-1501
SAGE-547
Lubiprostone
Plecanatide
SGX301 (synthetic hypericin)
TRC105 and Avastin
Levosimendan
VRS-317 VITAL
VTP-38543
TTP273 - LOGRA
VY-AADC01 
RESOLVE steroid-releasing implant
Luspatercept
Dalantercept - DART Study
XOMA 358
MACI 
Rolapitant - intravenous (IV)
Baricitinib
Cerliponase alfa
Plecanatide
AST-OPC1
Ezutromid
Rucaparib ARIEL2
Abaloparatide-SC 
CVT-301
MDX (Metadoxine Extended Release (MG01CI))
AFM13
Plazomicin - EPIC trial
Tenapanor
Tivantinib (ARQ 197) METIV-HCC trial
PEG-PAL
CAP-1002 HOPE-Duchenne
CAP-1002 ALLSTAR 
Cimzia
EGP-437
FG-3019
SD-101 
Selinexor - SADAL 
LJPC-501
CARBAVANCE
NKTR-181 
Inhaled Amikacin Solution (BAY41-6551T)
OCR-002 (IV)
Apatorsen and Zytiga - Pacific trial
Tarextumab - PINNACLE trial
Factor VIIa-CTP
Tarextumab plus platinum chemotherapy and etoposide
Neratinib
Azedra
Vonapanitase (PRT-201) PATENCY-2
Translarna
AMT-060
AMT-060
Fostamatinib
RP-G28
SPN-812
SYN-004
Oliceridine (TRV130)
Aerosurf
XEN801
ZX008
ZP-Triptan
